TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 46.1 -1.2 (-2.54%) Jul 22
18.43
P/B:
13.84
Market Cap:
€ 7.08B ($ 8.06B)
Enterprise V:
€ 7.29B ($ 8.30B)
Volume:
600.00
Avg Vol (2M):
196.00
Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (STU:NKB2) Operating Data Charts